SERVICES
Comprehensive laboratory support for all phases of clinical trial testing.
Contact Us
Clinical Trial Testing & Lab Capabilities
Central Laboratory Services Extract the most value out of our network of five globally integrated central laboratories with the help of our scientific and operational experts. Specialty Testing Working as an extension of your team, our dedicated scientists can serve as your partner from lead optimization to commercialization. Bioanalytical Services Eight global sites offer expertise to help anticipate regulatory challenges and develop strategic solutions across the drug development continuum. CMC Analytics Preserve consistent quality and continuity of data in drug development with our centralized CMC testing approach. Precision Medicine We offer leading technology, biomarker and clinical trial design consultation, and expertise in cell and gene therapies and companion diagnostics. Accreditations Our global accreditations and lab certifications reinforce our commitment to quality and give partners peace of mind.
Trending Topics
Video
The Modulatory Effects of a PI3Kδ Specific Small Molecule Inhibitor (IOA-244) on Basophil Degranulation Measured by Flow Cytometry
During this short 8-minute presentation, our staff scientist Eirini Kamileri, PhD evaluates the performance of the IOA-244 drug (a selective PI3Kδ inhibitor), on IgE-induced basophilic activation, through flow cytometry.
Watch Now
Video
Validation of CLL ERIC MRD Flow Cytometry Panel in a CAP/CLIA-Compliant Model
During this short 11-minute video, our staff scientist Marc Campillos, PhD discusses validation for the CLL ERIC MRD flow cytometry assay in a CAP/CLIA-compliant model to confirm performance of the assay in terms of precision, sensitivity and stability, while including run pass fail criteria using QC reagents.
Watch Now
Webinar
Supporting CAR T-Cell Development with a Translational Biomarker Strategy
Biomarkers play a critical part in accelerating CAR T-cell development. This 25-minute session, delves into the importance of a translational biomarker strategy in assessing safety and efficacy to navigate regulatory pathways in rapid development of CAR T-cell therapies.
Watch On Demand
Whitepaper
De-Risk and Streamline Your Drug Substance & Drug Product Testing
The development of a new biologic requires effective management of time and risk. The drug manufacturing process will progress in scale and likely location for both drug substance and drug product.
Read More
Webinar
Challenges & Best Practices in Supporting Clinical Bioanalysis in China
In this on-demand webinar, learn more about the key considerations and best practices for supporting your global clinical trial with regulated bioanalysis in China. Topics covered include: special requirements for China submission studies, differences in global quality standards and technical expertise, resourcing and customs challenges in China, and advanced technologies for supporting existing and emerging modalities.
Read More
Info Sheet
Testing Solutions to Advance Your COVID-19 Clinical Trials
Developing a vaccine or therapeutic in response to the outbreak of the 2019 Novel Coronavirus (COVID-19) requires a laboratory with significant technical and cross-functional experience. Our Central Laboratories are prepared to support your COVID-19 studies.
Read More
Featured Video
Propel Your Biomarker Strategy
PhD-level leaders within our Biomarker Solution Center can provide specialized therapeutic area expertise to create a successful biomarker strategy for your next study.
Clinical Testing Services for Drug Development
Biomarker-driven trial design and testing add complexity to the drug development process, with laboratory support required at every phase.
We are committed to helping you navigate the process, providing comprehensive scientific and medical support to complement your drug development program.
Download our clinical trial lab testing brochure
Educational Insights
Visit the Knowledge Libraryto learn more about our industry.
Overcoming Bottlenecks in Quantifying Oligonucleotide Therapeutics: Using LC-MS/MS Technology and Expertise to Reduce Risk and Increase Your Speed to Market Developing bioanalytical solutions to support oligonucleotide drug programs can be challenging due to the unique physicochemical properties of these molecules. This whitepaper outlines both the established and the unique liquid chromatography and extraction technologies Covance has developed to ensure you remain at the forefront of oligonucleotide innovation. Learn how you can benefit from the workflows to: eliminate bottlenecks and accelerate timelines with state-of-the-art liquid chromatography, focused detection and extraction technologies that generate accurate and robust data, rapidly receive the results you need through world-class scientific expertise based on decades of experience in solving complex bioanalytical challenges and capitalize on the rapidly expanding oligonucleotide marketing with the support of technologies and expertise.
Read More
Exploratory and preclinical studies often require rapid development of assays. In creating novel immunoassays or providing cellular-based analysis, researchers must proactively plan for a transition to CAP/CLIA or GxP facility for qualification, method validation and implementation. These case studies showcase a number of challenging, high-profile projects supported by the Labcorp Drug Development Translational Biomarker Solutions (Labcorp Drug Development TBS) team.
Read More
In the rapidly evolving Chinese research and development (R&D) landscape, there are several key considerations for effectively supporting global clinical trials with regulated bioanalysis in China. This white paper discusses the current status of bioanalysis in the region, in-country support and local guidance strategies to combat potential challenges in supporting clinical bioanalysis within China.
Read More
Learn from three thought leaders in the field of immunotherapy as they share their knowledge on trends and advances across the entire spectrum of development.
Read More
